Inari Medical Inc
NASDAQ:NARI
Cash Flow Statement
Cash Flow Statement
Inari Medical Inc
| Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Net Income |
(1)
|
4
|
1
|
7
|
14
|
17
|
25
|
16
|
10
|
(1)
|
(15)
|
(22)
|
(29)
|
(28)
|
(16)
|
(3)
|
(2)
|
(24)
|
(57)
|
(79)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
4
|
4
|
5
|
5
|
5
|
5
|
7
|
9
|
12
|
15
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
1
|
1
|
2
|
2
|
4
|
7
|
11
|
23
|
25
|
28
|
31
|
26
|
29
|
32
|
36
|
38
|
40
|
43
|
46
|
49
|
|
| Other Non-Cash Items |
2
|
3
|
6
|
7
|
8
|
11
|
12
|
23
|
27
|
30
|
33
|
29
|
32
|
33
|
32
|
32
|
29
|
40
|
53
|
69
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
3
|
3
|
4
|
6
|
6
|
10
|
9
|
|
| Cash Interest Paid |
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(6)
|
(11)
|
(11)
|
(13)
|
(21)
|
(19)
|
(20)
|
(33)
|
(14)
|
(25)
|
(25)
|
(21)
|
(21)
|
(17)
|
(15)
|
0
|
3
|
1
|
20
|
10
|
|
| Cash from Operating Activities |
(5)
N/A
|
(4)
+19%
|
(3)
+26%
|
3
N/A
|
2
-30%
|
11
+495%
|
20
+74%
|
9
-55%
|
25
+188%
|
8
-70%
|
(3)
N/A
|
(10)
-273%
|
(14)
-37%
|
(7)
+51%
|
6
N/A
|
35
+488%
|
36
+3%
|
26
-29%
|
27
+7%
|
14
-48%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(3)
|
(3)
|
(4)
|
(4)
|
(5)
|
(6)
|
(10)
|
(13)
|
(14)
|
(15)
|
(13)
|
(11)
|
(10)
|
(8)
|
(6)
|
(6)
|
(6)
|
(7)
|
(11)
|
(13)
|
|
| Other Items |
0
|
0
|
0
|
0
|
(50)
|
(71)
|
(85)
|
(87)
|
(37)
|
(87)
|
(172)
|
(154)
|
(185)
|
(118)
|
(24)
|
(26)
|
(52)
|
(8)
|
(4)
|
(48)
|
|
| Cash from Investing Activities |
(3)
N/A
|
(3)
-9%
|
(4)
-7%
|
(4)
-14%
|
(55)
-1 233%
|
(77)
-40%
|
(95)
-23%
|
(101)
-6%
|
(51)
+49%
|
(102)
-100%
|
(185)
-82%
|
(165)
+11%
|
(195)
-19%
|
(126)
+36%
|
(30)
+76%
|
(32)
-5%
|
(58)
-84%
|
(15)
+74%
|
(14)
+2%
|
(61)
-318%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
165
|
165
|
165
|
167
|
3
|
7
|
6
|
182
|
182
|
184
|
184
|
10
|
10
|
11
|
11
|
10
|
10
|
10
|
|
| Net Issuance of Debt |
10
|
20
|
20
|
(10)
|
(20)
|
(30)
|
(30)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(4)
|
(5)
|
(5)
|
(6)
|
(7)
|
(8)
|
(9)
|
(10)
|
(11)
|
(11)
|
(12)
|
|
| Cash from Financing Activities |
10
N/A
|
20
+98%
|
185
+813%
|
154
-17%
|
144
-6%
|
136
-5%
|
(29)
N/A
|
5
N/A
|
4
-17%
|
178
+4 283%
|
177
-1%
|
178
+1%
|
177
-1%
|
3
-98%
|
2
-25%
|
2
-18%
|
1
-38%
|
(0)
N/A
|
(1)
-138%
|
(2)
-160%
|
|
| Change in Cash | |||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
|
| Net Change in Cash |
2
N/A
|
13
+500%
|
178
+1 287%
|
152
-14%
|
91
-41%
|
70
-23%
|
(104)
N/A
|
(87)
+16%
|
(22)
+75%
|
84
N/A
|
(12)
N/A
|
2
N/A
|
(33)
N/A
|
(130)
-300%
|
(22)
+83%
|
6
N/A
|
(21)
N/A
|
11
N/A
|
12
+16%
|
(48)
N/A
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
(8)
N/A
|
(7)
+8%
|
(7)
+10%
|
(1)
+78%
|
(4)
-145%
|
5
N/A
|
10
+82%
|
(4)
N/A
|
12
N/A
|
(8)
N/A
|
(16)
-114%
|
(21)
-31%
|
(24)
-13%
|
(15)
+37%
|
(0)
+98%
|
29
N/A
|
30
+1%
|
18
-38%
|
17
-9%
|
2
-91%
|
|